These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 28774565

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Reference antigen-free and antibody-free LTD-IDMS assay for influenza H7N9 vaccine in vitro potency determination.
    Morgenstern K, Xie Y, Palladino G, Barr JR, Settembre EC, Williams TL, Wen Y.
    Vaccine; 2018 Oct 01; 36(41):6144-6151. PubMed ID: 30194004
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Quantification of immunoreactive viral influenza proteins by immunoaffinity capture and isotope-dilution liquid chromatography-tandem mass spectrometry.
    Pierce CL, Williams TL, Moura H, Pirkle JL, Cox NJ, Stevens J, Donis RO, Barr JR.
    Anal Chem; 2011 Jun 15; 83(12):4729-37. PubMed ID: 21591780
    [Abstract] [Full Text] [Related]

  • 8. Development of influenza A(H7N9) candidate vaccine viruses with improved hemagglutinin antigen yield in eggs.
    Ridenour C, Johnson A, Winne E, Hossain J, Mateu-Petit G, Balish A, Santana W, Kim T, Davis C, Cox NJ, Barr JR, Donis RO, Villanueva J, Williams TL, Chen LM.
    Influenza Other Respir Viruses; 2015 Sep 15; 9(5):263-70. PubMed ID: 25962412
    [Abstract] [Full Text] [Related]

  • 9. Development and applications of universal H7 subtype-specific antibodies for the analysis of influenza H7N9 vaccines.
    Gravel C, Elmgren C, Muralidharan A, Hashem AM, Jaentschke B, Xu K, Widdison J, Arnold K, Farnsworth A, Rinfret A, Van Domselaar G, Wang J, Li C, Li X.
    Vaccine; 2015 Feb 25; 33(9):1129-34. PubMed ID: 25620245
    [Abstract] [Full Text] [Related]

  • 10. A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice.
    Wang Y, Wu J, Xue C, Wu Z, Lin Y, Wei Y, Wei X, Qin J, Zhang Y, Wen Z, Chen L, Liu GD, Cao Y.
    Antiviral Res; 2017 Jul 25; 143():97-105. PubMed ID: 28408133
    [Abstract] [Full Text] [Related]

  • 11. H7N9 pandemic preparedness: A large-scale production of a split inactivated vaccine.
    Adami EA, Chavez Rico SL, Akamatsu MA, Miyaki C, Raw I, de Oliveira D, Comone P, Oliveira RDN, Sarno de Oliveira ML, Estima Abreu PA, Takano CY, Meros M, Soares-Schanoski A, Lee Ho P.
    Biochem Biophys Res Commun; 2021 Mar 19; 545():145-149. PubMed ID: 33550095
    [Abstract] [Full Text] [Related]

  • 12. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP, Blanchfield K, Belser JA, Music N, Tzeng WP, Holiday C, Burroughs A, Sun X, Maines TR, Levine MZ, York IA.
    J Virol; 2017 Oct 15; 91(20):. PubMed ID: 28768855
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of the Immune Responses to and Cross-Protective Efficacy of Eurasian H7 Avian Influenza Viruses.
    Kwon HI, Kim YI, Park SJ, Song MS, Kim EH, Kim SM, Si YJ, Lee IW, Song BM, Lee YJ, Yun SJ, Kim WJ, Choi YK.
    J Virol; 2017 Jun 01; 91(11):. PubMed ID: 28331080
    [Abstract] [Full Text] [Related]

  • 16. Antibodies to antigenic site A of influenza H7 hemagglutinin provide protection against H7N9 challenge.
    Schmeisser F, Vasudevan A, Verma S, Wang W, Alvarado E, Weiss C, Atukorale V, Meseda C, Weir JP.
    PLoS One; 2015 Jun 01; 10(1):e0117108. PubMed ID: 25629172
    [Abstract] [Full Text] [Related]

  • 17. Development of an Inactivated H7N9 Subtype Avian Influenza Serological DIVA Vaccine Using the Chimeric HA Epitope Approach.
    Sun Z, Wang Q, Li G, Li J, Chen S, Qin T, Ma H, Peng D, Liu X.
    Microbiol Spectr; 2021 Oct 31; 9(2):e0068721. PubMed ID: 34585985
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.